Home >  News >  Industry >  Pharma News >  Make India manufacturing...

Make India manufacturing hub: Mansukh Mandaviya urges Pharma industry

By - Ruchika Sharma
Published On 2021-10-28 08:47 GMT   |   Update On 2021-10-28 08:47 GMT
Advertisement

New Delhi: Union Chemicals and Fertilisers Minister Mansukh Mandaviya on Wednesday urged the pharma industry to make India manufacturing hub as the country is a safe destination for investments.

Addressing the Investor Summit on 'Opportunities & Partnerships in Pharma & Medical Devices', he also spoke about the government's pro-industry reforms and efforts to make India the best investment destination in the world.
"I would like to tell investors what Prime Minister Modi has already said. Please come and manufacture in India, set up industry here. The country provides a safe investment environment as you would find in your own countries," Mandaviya said during an online event.
He noted that the government has been taking constant steps to enhance investments in the country and the global pharma industry should benefit from it.
Advertisement
There were no biases against people coming to invest from outside and everyone was treated equally, he said, outlining the reasons for growth of the industry in the country.
Mandaviya, who is also the Union health minister, said the government is looking to make the country a pharma hub and noted that the government is in the process of setting up three bulk drug parks in the country.
Around Rs 30,000 crore has been lined up as part of the two Production-Linked Incentive (PLI) schemes in the pharma sector, Mandaviya said.
Further, he noted that India is rightly called the pharmacy of the world as it is the largest manufacturer and supplier of generic medicines.
During the COVID period, the country supplied medicines to more than 150 countries, the minister noted.
"It shows that the pharma industry is not just a business in India. It is connected with our sentiments. It is not governed with only profit motive but is guided by the Indian philosophy of Vasudhaiva Kutumbakam," he added.
Further, the minister said the domestic pharma industry has witnessed growth in COVID times and it has been due to the pro-industry policies formed by the government.
He assured investors that they will be treated fairly in India, given its robust regulatory mechanism, independent judiciary and democratic form of government.
Mandaviya stated that under the able leadership of the prime minister. India strives to become the best investment destination in the world for the pharma sector.
He noted that the pharma sector has witnessed a substantial increase in investments.
FDI in the sector increased 98 per cent year on year in 2020 and exports from India grew by 18 per cent in the last financial year.
The Investor Summit was organised by the Department of Pharmaceuticals in partnership with Invest India.

Read also: With 100 crore COVID vaccine doses mark, India's role as pharmacy of world becomes more entrenched



Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

Akums Drugs, Zambia Govt Ink USD 50 Mn Medicine Supply Deal, Pharma Plant by 2028

USFDA Suspends Ixchiq Chikungunya Vaccine License Citing Encephalitis Death, 20+ Serious Adverse Events

Aurobindo Pharma's subsidiary CuraTeQ Biologics Secures MHRA Approval for Trastuzumab Biosimilar Dazublys in HER2-Positive Cancer

Royalty Pharma to Buy USD 950 Million Royalty Stake in Amgen's Small Cell Lung Cancer Drug Imdelltra

Sun Pharma Wins CDSCO Panel Approval for Phase III Vitiligo Trial of Ruxolitinib Cream

Chhattisgarh Pharma Firm Slapped Recall Notice Over Defective Paracetamol Tablets

Crime Branch Busts Illegal Psychotropic Drug Trade, Pharmacist Among 3 Held

Delhi HC Cancels UNKIND Trademark, Upholds Mankind Pharma's KIND Family Rights